HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Peter Gregersen Selected Research
Peter Gregersen Research Topics
Disease
4
Rheumatoid Arthritis
01/2020 - 05/2006
3
Autoimmune Diseases (Autoimmune Disease)
06/2022 - 01/2016
2
Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2022 - 01/2021
2
Breast Neoplasms (Breast Cancer)
09/2009 - 03/2008
1
Pelvic Pain
01/2023
1
Myositis (Idiopathic Inflammatory Myopathies)
06/2022
1
Klinefelter Syndrome (Klinefelter's Syndrome)
06/2022
1
Systemic Scleroderma (Systemic Sclerosis)
06/2022
1
COVID-19
01/2022
1
Atherosclerosis
01/2021
1
Spinal Cord Injuries (Spinal Cord Injury)
01/2018
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2016
1
Necrosis
01/2016
1
Chronic Disease (Chronic Diseases)
02/2013
1
Rheumatic Diseases (Rheumatism)
03/2012
1
Coma (Comas)
05/2011
1
Asthma (Bronchial Asthma)
01/2011
1
Neoplasms (Cancer)
09/2009
Drug/Important Bio-Agent (IBA)
2
Cytokines
IBA
01/2020 - 01/2011
2
Proteins (Proteins, Gene)
FDA Link
01/2020 - 03/2008
2
Immunoglobulin G (IgG)
IBA
01/2016 - 03/2012
1
6-chloro-2-(1-piperazinyl)pyrazine (CPP)
IBA
01/2023
1
Complement System Proteins (Complement)
IBA
06/2022
1
Interferons
IBA
06/2022
1
Autoantibodies
IBA
01/2022
1
tofacitinib
IBA
01/2021
1
Janus Kinase Inhibitors
IBA
01/2021
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020
1
Member 25 Tumor Necrosis Factor Receptors
IBA
01/2020
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
02/2013
1
Peptides (Polypeptides)
IBA
03/2012
1
Polysaccharides (Glycans)
IBA
03/2012
1
Methotrexate (Mexate)
FDA Link
Generic
03/2012
1
Environmental Pollutants (Pollutants, Environmental)
IBA
01/2011
1
Thymic Stromal Lymphopoietin
IBA
01/2011
1
Smoke
IBA
01/2011
1
Vehicle Emissions (Emissions, Vehicle)
IBA
01/2011
1
Estrogen Receptors
IBA
09/2009
1
Fatty Acids (Saturated Fatty Acids)
IBA
03/2008
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
03/2008
1
HLA-DRB1 Chains (HLA DRB1)
IBA
05/2006
Therapy/Procedure
2
Therapeutics
01/2016 - 03/2012
1
Critical Care (Surgical Intensive Care)
05/2011